Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Operating Expenses | 1,356 | 1,237 | 1,585 | 1,115 | 1,302 |
| Operating Income | -1,356 | -1,237 | -1,585 | -1,115 | -1,302 |
| Interest Expense | 5 | 3 | 4 | 5 | 2 |
| Other Income | 23 | 54 | -16 | -267 | -41 |
| Pre-tax Income | -1,338 | -1,186 | -1,605 | -1,387 | -1,345 |
| Net Income Continuous | -1,337 | -1,185 | -1,606 | -1,386 | -1,345 |
| Net Income | $-1,337 | $-1,185 | $-1,606 | $-1,386 | $-1,345 |
| EPS Basic Total Ops | -0.03 | -0.05 | -0.05 | 0.00 | -0.05 |
| EPS Basic Continuous Ops | -0.03 | -0.05 | -0.05 | 0.00 | -0.05 |
| EPS Diluted Total Ops | -0.03 | -0.05 | -0.05 | 0.00 | -0.05 |
| EPS Diluted Continuous Ops | -0.03 | -0.05 | -0.05 | 0.00 | -0.05 |
| EBITDA(a) | $-1,330 | $-1,180 | $-1,598 | $-1,379 | $-1,340 |